| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Short Update on the Use of Monoclonal Antibodies in COVID-19
|
Vitiello, Antonio
|
|
|
26 |
2 |
|
artikel
|
| 2 |
Biodistribution of Drug/ADA Complexes: The Impact of Immune Complex Formation on Antibody Distribution
|
Opolka-Hoffmann, Eugenia
|
|
|
26 |
2 |
|
artikel
|
| 3 |
Characterization of CYP3A5 Selective Inhibitors for Reaction Phenotyping of Drug Candidates
|
Chen, Jie
|
|
|
26 |
2 |
|
artikel
|
| 4 |
Correction: Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
|
Saadeddin, Anas
|
|
|
26 |
2 |
|
artikel
|
| 5 |
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
|
Williams, Jason H.
|
|
|
26 |
2 |
|
artikel
|
| 6 |
Investigation of Antibody Pharmacokinetics in the Brain Following Intra-CNS Administration and Development of PBPK Model to Characterize the Data
|
Wu, Shengjia
|
|
|
26 |
2 |
|
artikel
|
| 7 |
Quality by Design Framework Applied to GMMA Purification
|
Giannelli, Carlo
|
|
|
26 |
2 |
|
artikel
|
| 8 |
Science- and Risk-Based Stability Strategies to Support Product Lifecycle Changes
|
McCaig, Lori
|
|
|
26 |
2 |
|
artikel
|
| 9 |
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA
|
Fang, Lanyan
|
|
|
26 |
2 |
|
artikel
|
Tijdschrift beschrijving